Projected Income Statement: Vext Science, Inc.

Forecast Balance Sheet: Vext Science, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 7.64 32.2 29.9 34.9 - -19.5 -8.7 8.9
Change - 321.47% -7.14% 16.72% - - 55.38% 202.3%
Announcement Date 4/20/22 A 3/22/23 A 5/10/24 A 3/31/25 A 4/29/26 A - - -
1USD in Million
Estimates

Cash Flow Forecast: Vext Science, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 18.78 8.86 2.737 1.465 - 2.495 1.351 1.535
Change - -52.83% -69.11% -46.46% - - -45.85% 13.62%
Free Cash Flow (FCF) 1 -7.102 -2.938 1.688 1.823 8.145 4.192 16.18 22.4
Change - 58.64% 157.45% 8.04% 346.73% -48.53% 286.07% 38.38%
Announcement Date 4/20/22 A 3/22/23 A 5/10/24 A 3/31/25 A 4/29/26 A - - -
1CAD in Million
Estimates

Forecast Financial Ratios: Vext Science, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

         
EBITDA Margin (%) - 35.96% 42.69% 15.88% 25.43% - 45.26% 29.78% 30.86%
EBIT Margin (%) - - - -22.53% -31.06% - 4.65% 8.86% 13.02%
EBT Margin (%) - - - - - -29.62% -0.56% 6.3% 10.42%
Net margin (%) - - - - - -35.03% -1.67% 4.68% 8.85%
FCF margin (%) - -19.07% -8.3% 4.85% 5.06% 15.86% 7.79% 23.51% 29.16%
FCF / Net Income (%) - - - - - -45.27% -465.78% 502.53% 329.35%

Profitability

         
ROA 4.29% 7.17% 5.67% -3.62% -5.04% -3.37% - - -
ROE 6.86% 10.42% 16.63% 5.27% -26.28% -27.96% - - -

Financial Health

         
Leverage (Debt/EBITDA) - 0.57x 2.13x 5.4x 3.81x - - - 0.38x
Debt / Free cash flow - -1.08x -10.97x 17.7x 19.14x - - - 0.4x

Capital Intensity

         
CAPEX / Current Assets (%) - 50.43% 25.02% 7.86% 4.07% - 4.64% 1.96% 2%
CAPEX / EBITDA (%) - 140.24% 58.61% 49.52% 16.01% - 10.25% 6.59% 6.48%
CAPEX / FCF (%) - -264.47% -301.62% 162.18% 80.37% - 59.52% 8.35% 6.85%

Items per share

         
Cash flow per share 1 - 0.1008 0.0583 0.0367 0.0197 - - - -
Change - - -42.2% -37.04% -46.35% - - - -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - - - - - - - -
Change - - - - - - - - -
EPS 1 - - - 0.041 -0.115 -0.0958 - 0.014 0.041
Change - - - - -380.53% 16.71% - - 192.86%
Nbr of stocks (in thousands) - 136,713 148,963 217,484 247,443 251,034 247,684 247,684 247,684
Announcement Date - 4/20/22 A 3/22/23 A 5/10/24 A 3/31/25 A 4/29/26 A - - -
1CAD
Estimates
2026 *2027 *
P/E - 20.7x
PBR - -
EV / Sales 0.6x 0.63x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2900CAD
Average target price
0.9500CAD
Spread / Average Target
+227.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VEXT Stock
  4. VV5 Stock
  5. Financials Vext Science, Inc.